Alumis Inc. is a precision medicines company with the mission to transform the lives of patients with autoimmune diseases. Even with treatment innovations of the last two decades, many patients with immunologic conditions continue to suffer - our goal is to fundamentally change the outcomes for these patients.
We are seeking an experienced Senior Manager, FP&A – Research & Technical Operations to join our team in a fast-paced, high-growth environment. This position will serve as a strategic finance business partner to the Research and Technical Operations organizations, supporting a growing portfolio of programs and operational priorities. In this role, you will play a critical part in driving planning and forecasting processes, delivering decision support for functional leadership, and assisting the Sr. Director of FP&A in overall planning strategy and execution. This position will also involve close interaction with the Accounting team during month-end close processes.
Responsibilities
- Partner closely with Research and Technical Operations teams to provide effective planning, forecasting, and analysis; provide senior leadership and business partners with appropriate tools and insights to set goals and measure performance.
- Attend cross-functional program and functional leadership meetings; proactively identify risks, opportunities, and tradeoffs and translate them into clear financial implications.
- Partner with Technical Operations and Accounting to support COGS and gross margin planning/forecasting and related performance analysis.
- Support Technical Operations’ operating models by validating key assumptions, running scenarios, and communicating financial implications to functional leaders.
- Own financial reporting for supported functions, including monthly comparison of actual vs. budget/forecast results and relevant variance analysis, in a timely and accurate manner.
- Collaborate with the Accounting team on monthly close to ensure accruals and expenses are recorded accurately and promptly.
- Assist Sr. Director, FP&A in the management of the LRP and budget processes, support compliance of internal controls, preparation of finance materials for the Board, and other high priority projects.
- Collaborate, influence, and build credibility with business partners across the organization, especially within Research and Technical Operations.
- Educate program and functional leaders about the budgeting/forecasting process and the importance of their role in a successful process.
Qualifications
- Bachelor’s in Finance, Accounting or relevant degree.
- 7+ years of progressive financial reporting, planning and analysis experience in the pharmaceutical or biotechnology industry.
- Prior experience supporting Research/R&D and/or Technical Operations organizations is highly preferred.
- Experience supporting manufacturing/CMC/supply chain finance and partnering through commercialization or launch-readiness activities is a plus.
- System savvy, ideally with experience implementing or overseeing financial planning and reporting tools. Experience with Adaptive Insights is a plus.
- Strong and advanced Excel modeling and analytical skills as well as solid accounting knowledge.
- Strong written, verbal, and interpersonal skills.
Alumis Values
• We Elevate
• We Challenge
• We Nurture
This position is located in South San Francisco, CA and employees are expected to be onsite Tuesday-Thursday.
The salary range for this position is $165,000 USD to $200,000 USD annually. This salary range is an estimate, and the actual salary may vary based on the Company’s compensation practices.
Alumis Inc. is an equal opportunity employer.
Similar Jobs
What We Do
At Alumis, our goal is to significantly improve the lives of patients by replacing broad immunosuppression with targeted therapies. We recognize that patients living with immune-mediated diseases need alternatives to currently available therapies. Despite recent advances and innovations in the treatment of immune-mediated diseases, many patients continue to suffer, cycling through currently approved therapies while looking for a solution that alleviates the debilitating impact of their disease without life-limiting side effects. Addressing the needs of these patients is why we exist. We are pioneering a precision approach that leverages insights we derive from powerful data analytics to select the right target, right molecule, right indication, right patient, and right endpoint resulting in optimized outcomes for patients. We believe that combining our insights with an integrated approach to drug development will produce the next generation of treatments to address immune dysfunction. Incubated by Foresite Labs, Alumis is led by a team of deeply experienced professionals who are devoted to transforming the lives of patients with immune-mediated diseases by developing a pipeline of transformative therapies.
